Phase II Trial of Velcade + Vorinostat in the Treatment of High Risk MDS and Relapsed/Refractory AML
|Effective start/end date||1/1/08 → 12/31/13|
- MERCK AND CO INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.